Tandem Diabetes Care (FRA:TD5A) Additional Paid-In Capital : €1,139.4 Mil(As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Tandem Diabetes Care Additional Paid-In Capital?

Tandem Diabetes Care's quarterly additional paid-in capital declined from Sep. 2023 (€1,159.9 Mil) to Dec. 2023 (€1,159.1 Mil) but then stayed the same from Dec. 2023 (€1,159.1 Mil) to Mar. 2024 (€1,139.4 Mil).

Tandem Diabetes Care's annual additional paid-in capital increased from Dec. 2021 (€945.4 Mil) to Dec. 2022 (€1,105.3 Mil) and increased from Dec. 2022 (€1,105.3 Mil) to Dec. 2023 (€1,159.1 Mil).

Tandem Diabetes Care Additional Paid-In Capital Historical Data

The historical data trend for Tandem Diabetes Care's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tandem Diabetes Care Additional Paid-In Capital Chart

Tandem Diabetes Care Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

737.66

842.74

945.41

1,105.32

1,159.09

Tandem Diabetes Care Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															1,113.18	1,125.32	1,159.95	1,159.09	1,139.37

Tandem Diabetes Care Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Tandem Diabetes Care Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Tandem Diabetes Care's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Tandem Diabetes Care (FRA:TD5A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tandem Diabetes Care Inc (FRA:TD5A) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

TNDM:USA

Address

11075 Roselle Street, San Diego, CA, USA, 92121

Website

https://www.tandemdiabetes.com

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. Nearly three quarters of total revenue is derived from the U.S., with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Tandem Diabetes Care (FRA:TD5A) Headlines

No Headlines